House Dems: Exclusivity period on biologics shouldn't be in trade deals

08/8/2011 | Hill, The

The 12-year exclusivity period for biologic drugs should not be subject to negotiation in the ongoing Trans-Pacific Partnership talks, a group of House Democrats told President Barack Obama. "Were the TPP to ultimately contain a 12-year biologics exclusivity provision, it would impede the ability of Congress to achieve the Administration's proposed 7-year change without running afoul of U.S. trade obligations," the representatives wrote to Obama.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI